pRC/CMV-TYK2VF/PA-VSV
(Plasmid
#139351)
-
PurposeExpression of the double mutant of TYK2-V678F-P1104A
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 139351 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRC/CMV
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTYK2 cDNA with 267nt of 5' UTR
-
SpeciesH. sapiens (human)
-
MutationV362F-V678F-P1104A
-
Entrez GeneTYK2 (a.k.a. IMD35, JTK1)
- Promoter CMV
-
Tag
/ Fusion Protein
- VSV (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SgrAI (unknown if destroyed)
- 3′ cloning site XbaI (unknown if destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer Sp6 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRC/CMV-TYK2VF/PA-VSV was a gift from Sandra Pellegrini (Addgene plasmid # 139351 ; http://n2t.net/addgene:139351 ; RRID:Addgene_139351) -
For your References section:
Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent. Li Z, Gakovic M, Ragimbeau J, Eloranta ML, Ronnblom L, Michel F, Pellegrini S. J Immunol. 2013 Mar 1;190(5):2335-44. doi: 10.4049/jimmunol.1203118. Epub 2013 Jan 28. 10.4049/jimmunol.1203118 PubMed 23359498